Radical-Mediated Nucleophilic Peptide Cross-Linking in Dynobactin Biosynthesis
- PMID: 39528355
- PMCID: PMC11695099
- DOI: 10.1021/jacs.4c10425
Radical-Mediated Nucleophilic Peptide Cross-Linking in Dynobactin Biosynthesis
Abstract
Dynobactins are recently discovered ribosomally synthesized and post-translationally modified peptide (RiPP) antibiotics that selectively kill Gram-negative pathogens by inhibiting the β-barrel assembly machinery (Bam) located on their outer membranes. Such activity of dynobactins derives from their unique cross-links between Trp1-Asn4 and His6-Tyr8. In particular, the His6-Tyr8 cross-link is formed between Nτ of His6 and Cβ of Tyr8, an unprecedented type of cross-link in RiPP natural products. The mechanism of the C-N cross-link formation remains elusive. In this work, using in vitro characterizations, we demonstrate that both cross-links in dynobactins are biosynthesized by the radical S-adenosylmethionine (SAM) enzyme DynA. Subsequent mechanistic studies using deuterium-labeled DynB precursor peptides suggested that the C-N cross-linking proceeds through the Tyr8-Hβ atom abstraction by 5'-deoxyadenosyl radical. The absence of solvent exchange of Tyr8-Hα suggested that the mechanism unlikely involves α,β-desaturation of Tyr8. Furthermore, DynA catalyzed covalent modification of Tyr8 of H6A-DynB with small-molecule nucleophiles, suggesting the presence of a highly electrophilic Tyr-derived intermediate. Based on all these observations, we propose that DynA catalyzes Tyr8-Hβ atom abstraction to generate Tyr8-Cβ radical followed by its oxidation to a p-quinone methide intermediate, to which His6-Nτ attacks to form the C-N cross-link. This quinone methide-dependent mechanism of RiPPs cross-linking is distinct from the previously reported RiPPs cross-linking mechanisms and represents a novel mechanism in RiPPs biosynthesis. We will also discuss the functional, mechanistic, and evolutional relationships of DynA with other peptide-modifying radical SAM enzymes.
Conflict of interest statement
The authors declare no competing financial interest.
Figures










References
-
- Saxena D; Maitra R; Bormon R; Czekanska M; Meiers J; Titz A; Verma S; Chopra S Tackling the Outer Membrane: Facilitating Compound Entry into Gram-Negative Bacterial Pathogens. Npj Antimicrob. Resist 2023, 1 (1), 17.
-
- Imai Y; Meyer KJ; Iinishi A; Favre-Godal Q; Green R; Manuse S; Caboni M; Mori M; Niles S; Ghiglieri M; Honrao C; Ma X; Guo JJ; Makriyannis A; Linares-Otoya L; Böhringer N; Wuisan ZG; Kaur H; Wu R; Mateus A; Typas A; Savitski MM; Espinoza JL; O’Rourke A; Nelson KE; Hiller S; Noinaj N; Schäberle TF; D’Onofrio A; Lewis K A New Antibiotic Selectively Kills Gram-Negative Pathogens. Nature 2019, 576 (7787), 459–464. - PMC - PubMed
-
- Miller RD; Iinishi A; Modaresi SM; Yoo B-K; Curtis TD; Lariviere PJ; Liang L; Son S; Nicolau S; Bargabos R; Morrissette M; Gates MF; Pitt N; Jakob RP; Rath P; Maier T; Malyutin AG; Kaiser JT; Niles S; Karavas B; Ghiglieri M; Bowman SEJ; Rees DC; Hiller S; Lewis K Computational Identification of a Systemic Antibiotic for Gram-Negative Bacteria. Nat. Microbiol 2022, 7 (10), 1661–1672. - PMC - PubMed
-
- Knowles TJ; Scott-Tucker A; Overduin M; Henderson IR Membrane Protein Architects: The Role of the BAM Complex in Outer Membrane Protein Assembly. Nat. Rev. Microbiol 2009, 7 (3), 206–214. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous